1. 325. Feasibility of a combination of 90Y/177Lu-Radiopeptide Therapy (Peptide Receptor Radionuclide Therapy – PRRT) and External Beam Radiation Therapy (EBRT) in neuroendocrine tumors (NETs). (December 2018) Authors: Vitali, S.; Garibaldi, C.; Ferrari, M.E.; Botta, F.; Bodei, L.; Zerini, D.; Jereczek-Fossa, B.A.; Grana, C.M.; Orecchia, R.; Cremonesi, M. Journal: Physica medica Issue: Volume 56(2018)Supplement 2 Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors. (20th June 2013) Authors: Guerriero, F.; Ferrari, M. E.; Botta, F.; Fioroni, F.; Grassi, E.; Versari, A.; Sarnelli, A.; Pacilio, M.; Amato, E.; Strigari, L.; Bodei, L.; Paganelli, G.; Iori, M.; Pedroli, G.; Cremonesi, M. Other Names: Yang David J. Academic Editor. Journal: BioMed research international Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Planning combined treatments of external beam radiation therapy and molecular radiotherapy. (November 2015) Authors: Cremonesi, M.; Ferrari, M.; Botta, F.; Garibaldi, C.; Bodei, L.; Grana, C.M.; Orecchia, R. Journal: Physica medica Issue: Volume 31(2015)Supplement 2 Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1064: 90y/ 177Lu-radiopeptide therapy and external beam radiation therapy applied to neuroendocrine tumor patients. (April 2015) Authors: Cremonesi, M.; Garibaldi, C.; Ferrari, M.; Bodei, L.; Zerini, D.; Botta, F.; Cattani, F.; Jereczek, B.; Grana, C.; Pedroli, G.; Orecchia, R. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗